Human Microbiome Fusobacterium Nucleatum in Esophageal Cancer Tissue Is Associated with Prognosis

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890

Inflammation and metabolic disorders

Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199

Human gut microbes associated with obesity

Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785

The human microbiome: at the interface of health and disease

Cho, I., & Blaser, M. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3182 · Cited by 3,449

The gut microbiota, bacterial metabolites and colorectal cancer

Louis, P., Hold, G. L., & Flint, H. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3344 · Cited by 2,925

Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment

Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718

Esophageal Cancer

Enzinger, P. C., & Mayer, R. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035010 · Cited by 2,613

Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin

Rubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476

Intestinal inflammation targets cancer-inducing activity of the microbiota

Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)

McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji237 · Cited by 2,162

A nomogram to predict short-term outcome of radiotherapy or chemoradiotherapy based on pre/post-treatment inflammatory biomarkers and their dynamic changes in esophageal squamous cell carcinoma

Liang, S., Li, C., Gao, Z., Li, J., Zhao, H., Yu, J., & Meng, X. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107178 · Cited by 19

Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapy

Schmidt, M., HACKETT, R. J., Baker, A., McDonald, S. A. C., Quante, M., & Graham, T. A. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00531-4 · Cited by 17

Oral Microbiota Variation: A Risk Factor for Development and Poor Prognosis of Esophageal Cancer

Song, X., Greiner-Tollersrud, O. K., & Zhou, H. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07245-2 · Cited by 19

Circulating tumour cells in gastrointestinal cancers: food for thought?

Asawa, S., Nüesch, M., Gvozdenovic, A., & Aceto, N. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02228-8 · Cited by 17

Immuno-oncology-microbiome axis of gastrointestinal malignancy

Lin, Q., Guan, S.-W., & Yu, H. (2023) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v15.i5.757 · Cited by 20

Prognostic Significance of the Microbiome and Stromal Cells Phenotype in Esophagus Squamous Cell Carcinoma

Kovaleva, O. V., Алексеевна, П. П., Rashidova, M. A., Samoilova, D. V., Petrenko, A., Mochalnikova, V. V., Kataev, V., Khlopko, Y. A., Plotnikov, A. O., & Gratchev, A. N. (2021) · Biomedicines · doi:10.3390/biomedicines9070743 · Cited by 18

Nutrition and Cancer Risk from the Viewpoint of the Intestinal Microbiome

Tanaka, Y., Shimizu, S., Shirotani, M., Yorozu, K., Kitamura, K., Oehorumu, M., Kawai, Y., & Fukuzawa, Y. (2021) · Nutrients · doi:10.3390/nu13103326 · Cited by 20

Does microbiome shift play a role in carcinogenesis? A systematic review

Mallika, L., Augustine, D., Rao, R. S., Patil, S., Alamir, A. H., Awan, K. H., Sowmya, S., Haragannavar, V. C., & Prasad, K. (2020) · Translational Cancer Research · doi:10.21037/tcr.2020.02.11 · Cited by 17

Intratumoral Fusobacterium nucleatum in Pancreatic Cancer: Current and Future Perspectives

D’Antonio, D. L., Zenoniani, A., Umme, S., Piattelli, A., & Curia, M. C. (2024) · Pathogens · doi:10.3390/pathogens14010002 · Cited by 21

Porphyromonas gingivalis -OMVs promote the epithelial-mesenchymal transition of oral squamous cell carcinoma by inhibiting ferroptosis through the NF-κB pathway

Liao, X., Si, H., Lai, Y., Zhang, X., Feng, Y., Zhou, T., Feng, Y., & Yu, L. (2025) · Journal of Oral Microbiology · doi:10.1080/20002297.2025.2482924 · Cited by 18

The Link between Periodontal Disease and Oral Cancer—A Certainty or a Never-Ending Dilemma?

Surlari, Z., Virvescu, D. I., Baciu, E.-R., Vasluianu, R.-I., & Budală, D. G. (2021) · Applied Sciences · doi:10.3390/app112412100 · Cited by 17

Dietary riboflavin deficiency induces genomic instability of esophageal squamous cells that is associated with gut microbiota dysbiosis in rats

Pan, F., Xu, X., Zhang, L.-L., Luo, H., Chen, Y., Long, L., Wang, X., Zhuang, P.-T., Li, E., & Xu, L. (2020) · Food & Function · doi:10.1039/d0fo01944e · Cited by 17

The rise and evolving role of Fusobacterium nucleatum subspecies

Wolf, M., Steinberg, T., Scholz, K. J., Kruse, A., Rezasoltani, S., Conrads, G., Al‐Ahmad, A., & Cieplik, F. (2025) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2025.100414 · Cited by 15

Fusobacteria: physiology, form, and function

Robinson, A. V., Wilde, J., & Allen‐Vercoe, E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819672-4.00006-4 · Cited by 17

PHF20 Promotes Glioblastoma Cell Malignancies Through a WISP1/BGN-Dependent Pathway

Ma, Q., Long, W., Xing, C., Jiang, C., Su, J., Wang, H. Y., Liu, Q., & Wang, R.-F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.573318 · Cited by 16

Commensal microbes and p53 in cancer progression

Celardo, I., Melino, G., & Amelio, I. (2020) · Biology Direct · doi:10.1186/s13062-020-00281-4 · Cited by 17

Human Microbiota in Esophageal Adenocarcinoma: Pathogenesis, Diagnosis, Prognosis and Therapeutic Implications

Dan, W., Peng, L., Yan, B., Li, Z., & Pan, F. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.791274 · Cited by 16

Evaluating Alterations of the Oral Microbiome and Its Link to Oral Cancer among Betel Quid Chewers: Prospecting Reversal through Probiotic Intervention

Diwan, P., Nirwan, M., Bahuguna, M., Kumari, S. P., Wahlang, J., & Gupta, R. K. (2023) · Pathogens · doi:10.3390/pathogens12080996 · Cited by 20

Oral Microbial Profile Analysis in Patients with Oral and Pharyngeal Cancer Reveals That Tumoral Fusobacterium nucleatum Promotes Oral Cancer Progression by Activating YAP

Yamamoto, Y., Kamiya, T., Yano, M., Huyen, V. T., Oishi, M., Nishio, M., Suzuki, A., Sunami, K., & Ohtani, N. (2023) · Microorganisms · doi:10.3390/microorganisms11122957 · Cited by 19

Causal relationship between gut microbiota and risk of esophageal cancer: evidence from Mendelian randomization study

Wang, K., Wang, J., Chen, Y., Long, H., Pan, W., Liu, Y., Xu, M., & Guo, Q. (2024) · Aging · doi:10.18632/aging.205547 · Cited by 16

Mechanistic Insights on Microbiota-Mediated Development and Progression of Esophageal Cancer

Moe, K. T., & Tan, K. S. W. (2024) · Cancers · doi:10.3390/cancers16193305 · Cited by 16

The esophageal mucosal barrier in health and disease: mucosal pathophysiology and protective mechanisms

Gyawali, C. P., Sonu, I. S., Becker, L. S., & Sarosiek, J. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14521 · Cited by 16

Harnessing Tissue Engineering Tools to Interrogate Host-Microbiota Crosstalk in Cancer

Udayasuryan, B., Nguyen, T. T. D., Slade, D. J., & Verbridge, S. S. (2020) · iScience · doi:10.1016/j.isci.2020.101878 · Cited by 15

Advancements in understanding tumor‑resident bacteria and their application in cancer therapy

Luo, Y., Huang, X., Wang, R., Lin, Y., Sun, J., Li, K., Wang, D. Y., Yan, Y., & Qiao, Y. (2025) · Military Medical Research · doi:10.1186/s40779-025-00623-1 · Cited by 16

Intratumoral microbiota remodeling of the tumor microenvironment impact solid tumor immunotherapy

Jia, J., Gao, W., Wang, C., Liu, L., Li, Y., Sun, Z., Yang, C., Chen, Y., Yu, H., & Cheng, Y. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08211-w · Cited by 18

Standardized studies of the oral microbiome: From technology‐driven to hypothesis‐driven

Gao, C., Li, X., Zhao, X., Yang, P., Wang, X., Chen, X., Chen, N., & Chen, F. (2022) · iMeta · doi:10.1002/imt2.19 · Cited by 15

Comprehensive analysis of microbiota signature across 32 cancer types

Yang, X., An, H., He, Y., Fu, G., & Jiang, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1127225 · Cited by 15

A new member of the flavodoxin superfamily from Fusobacterium nucleatum that functions in heme trafficking and reduction of anaerobilin

McGregor, A. K., Chan, A., Schroeder, M. D., Do, L. T. M., Saini, G., Murphy, M. E. P., & Wolthers, K. R. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104902 · Cited by 13

A discussion of the gut microbiome’s development, determinants, and dysbiosis in cancers of the esophagus and stomach

Grover, K., Gregory, S., Gibbs, J. F., & Emenaker, N. J. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-2019-gi-07 · Cited by 16

Oral microbiota and vitamin D impact on oropharyngeal squamous cell carcinogenesis: a narrative literature review

Zanetta, P., Squarzanti, D. F., Sorrentino, R., Rolla, R., Valletti, P. A., Garzaro, M., Dell’Era, V., Amoruso, A., & Azzimonti, B. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1872487 · Cited by 15

Human papillomavirus infection and tumor microenvironment are associated with the microbiota in patients with oropharyngeal cancers—pilot study

Zakrzewski, M., Gannon, O. M., Panizza, B. J., Saunders, N. A., & Antonsson, A. (2021) · Head & Neck · doi:10.1002/hed.26821 · Cited by 14

Gastrointestinal disorders and intestinal bacteria: Advances in research and applications in therapy

Ohkusa, T., Nishikawa, Y., & Sato, N. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.935676 · Cited by 16

The multi-kingdom cancer microbiome

Dohlman, A. B., Pan, X., Zitvogel, L., & Iliev, I. D. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02103-7 · Cited by 16

Microbiomes in pancreatic cancer can be an accomplice or a weapon

Guo, X., Wang, P., Li, Y., Chang, Y., & Wang, X. S. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104262 · Cited by 15

Human gut-microbiome interplay: Analysis of clinical studies for the emerging roles of diagnostic microbiology in inflammation, oncogenesis and cancer management

Jiang, Z., Li, L., Chen, J., Wei, G., Ji, Y., Chen, X., Liu, J., & Huo, J.-G. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104946 · Cited by 14

Influence of Pre-treatment Saliva Microbial Diversity and Composition on Nasopharyngeal Carcinoma Prognosis

Du, Y., Feng, R., Chang, E. T., Debelius, J. W., Yin, L., Xu, M., Huang, T., Zhou, X., Xiao, X., Li, Y., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.831409 · Cited by 15

The oncomicrobiome: New insights into microorganisms in cancer

Ma, Y., Chen, T., Sun, T., Dilinuer, D., & Xiao, Y. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.107091 · Cited by 14

Beta-defensin index: A functional biomarker for oral cancer detection

Ghosh, S. K., Man, Y., Fraiwan, A., Waters, C., McKenzie, C., Lu, C. Y., Pfau, D., Kawsar, H. I., Bhaskaran, N., Pandiyan, P., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101447 · Cited by 13

Dysbiosis linking periodontal disease and oral squamous cell carcinoma-A brief narrative review

Acharya, S., Hegde, U., Acharya, A. B., & Nitin, P. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32259 · Cited by 8

Fecal Microbiome Composition Correlates with Pathologic Complete Response in Patients with Operable Esophageal Cancer Treated with Combined Chemoradiotherapy and Immunotherapy

Shaikh, F. Y., Lee, S., White, J. R., Zhao, Y., Ferri, J. T., Pereira, G., Landon, B. V., Ke, S., Hu, C., Feliciano, J. L., et al. (2024) · Cancers · doi:10.3390/cancers16213644 · Cited by 15

Tooth Loss Predicts Long-Term Prognosis of Esophageal Cancer After Esophagectomy

Miura, S., Nakamura, T., Hasegawa, T., Miura, Y., Takiguchi, G., Urakawa, N., Hasegawa, H., Yamamoto, M., Kanaji, S., Matsuda, Y., et al. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07903-w · Cited by 13

Fusobacterium nucleatum in Health and Disease

Yang, X., Zhang, S., Ning, T., & Wu, J. (2025) · MedComm · doi:10.1002/mco2.70465 · Cited by 15

Bacteria and macrophages in the tumor microenvironment

Xu, S. S., Xiong, Y., Fu, B., Guo, D. L., Sha, Z., Lin, X., & Wu, H. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1115556 · Cited by 13

The colorectal cancer-specific microbiome regulation and immune response activation via an artificial biomimetic nanovaccine

Zhuang, X., Li, B., Liu, X., Fan, T., Lan, X., Wang, X., & Yu, M. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.141982 · Cited by 12

Immuno-genomic analysis reveals eosinophilic feature and favorable prognosis of female non-smoking esophageal squamous cell carcinomas

Okawa, Y., Sasagawa, S., Kato, H., Johnson, T. A., Nagaoka, K., Kobayashi, Y., Hayashi, A., Shibayama, T., Maejima, K., Tanaka, H., et al. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216499 · Cited by 12

Upper gastrointestinal tract microbiota with oral origin in relation to oesophageal squamous cell carcinoma

Gao, S., Zhang, Z., Sun, K., Li, M.-X., & Qi, Y. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2295401 · Cited by 12

Nano-mupirocin as tumor-targeted antibiotic: Physicochemical, immunotoxicological and pharmacokinetic characterization, and effect on gut microbiome

Cern, A., Skoczen, S. L., Snapp, K. S., Hod, A., Zilbersheid, D., Bavli, Y., Alon‐Maimon, T., Bachrach, G., Wei, X., Berman, B., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.07.045 · Cited by 13

From microbes to medicine: harnessing the power of the microbiome in esophageal cancer

Liu, X., Li, B., Liang, L., Han, J., Mai, S., & Liu, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1450927 · Cited by 12

Subgingival Periopathogens Assessment and Clinical Periodontal Evaluation of Gastric Cancer Patients—A Cross Sectional Pilot Study

Nicolae, F. M., Didilescu, A. C., Șurlin, P., Ungureanu, B. S., Şurlin, V., Pătrașcu, Ș., Râmboiu, S., Jelihovschi, I., Iancu, L. S., Ghiluşi, M. C., et al. (2022) · Pathogens · doi:10.3390/pathogens11030360 · Cited by 12

Role of the Microbiome in the Diagnosis and Management of Gastroesophageal Cancers

Mascaretti, F., Haider, S., Amoroso, C., Caprioli, F., Ramai, D., & Ghidini, M. (2024) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-024-01021-x · Cited by 12

Friend or Foe: Exploring the Relationship between the Gut Microbiota and the Pathogenesis and Treatment of Digestive Cancers

Profir, M., Roşu, O., Creţoiu, S. M., & Gașpar, B. S. (2024) · Microorganisms · doi:10.3390/microorganisms12050955 · Cited by 12

Effectiveness of an oral care tablet containing kiwifruit powder in reducing oral bacteria in tongue coating: A crossover trial

Matsumura, Y., Hinode, D., Fukui, M., Yoshioka, M., Asakuma, H., & Takii, H. (2019) · Clinical and Experimental Dental Research · doi:10.1002/cre2.262 · Cited by 12

Harnessing intratumoral microbiota: new horizons in immune microenvironment and immunotherapy

Zhang, J., You, Z., Li, X., Hu, J., Li, J., & Jing, Z. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06916-2 · Cited by 14

Fusobacterium nucleatum: a transboundary pathogen in host-microbiota networks

Gao, X., Cao, F., Li, Y., Huang, J., Hu, X., & Li, Z. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00775-4 · Cited by 11

Intratumoral microbiome: the double-edged sword in remodeling cancer immunotherapy

Yan, D., Yu, Y., Liang, C., Cui, Z., Shi, L., Li, G., & Ren, C. (2026) · Molecular Cancer · doi:10.1186/s12943-025-02566-6 · Cited by 11

Intratumoral microorganisms in tumors of the digestive system

Xuan, M., Gu, X., Liu, Y., Li, Y., Li, Y., Huang, D., Li, J., & Xue, C. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01425-5 · Cited by 13

The gut-tumor connection: the role of microbiota in cancer progression and treatment strategies

Wei, Z., Gao, G., He, Q., Kwok, L., & Sun, Z. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.08.038 · Cited by 12

A Nomogram Combining a Four-Gene Biomarker and Clinical Factors for Predicting Survival of Melanoma

Zhang, C., Dang, D., Wang, Y., & Cong, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.593587 · Cited by 11

Analysis of the Pancreatic Cancer Microbiome Using Endoscopic Ultrasound–Guided Fine-Needle Aspiration–Derived Samples

Nakano, S., Kawamoto, Y., Komatsu, Y., Saito, R., Ito, K., Yamamura, T., Harada, K., Yuki, S., Kawakubo, K., Sugiura, R., et al. (2022) · Pancreas · doi:10.1097/mpa.0000000000002028 · Cited by 11

Prevalence of Helicobacter pylori infection among patients with esophageal carcinoma

López-Gómez, M., Morales, M. M., Martínez, R. F., Muñoz, M., López, P. D. D., Gómez-Cerezo, J. F., & Casado, E. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i29.3479 · Cited by 11

Influence of Oral Intaking Habit on Tongue Coating Microbiota in Patients with Esophageal Precancerous Lesions

Xiao, P., Hua, Z., Kang, X., Lu, B., Li, M., Wu, J., Dong, W., Zhang, J., & Cheng, C. (2022) · Journal of Cancer · doi:10.7150/jca.67068 · Cited by 10

Exploring micronutrients and microbiome synergy: pioneering new paths in cancer therapy

Bhatnagar, K., Jha, K., Dalal, N., Patki, N., Gupta, G., Kumar, A., Kumar, A., & Chaudhary, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1442788 · Cited by 12

A Detection and Analysis of Fusobacterium Utilizing Changes in the Magnetic Properties of Magnetic Nanoparticles-Antibody–Antigen Aggregates

Yabukami, S., Murayama, T., Takahashi, S., Ohno, S., Washio, J., & Takahashi, N. (2022) · IEEE Transactions on Magnetics · doi:10.1109/tmag.2022.3161508 · Cited by 10

Are intratumoral microbiota involved in the progression of intraductal papillary mucinous neoplasms of the pancreas?

Hozaka, Y., Oi, H., Satake, S., Uchino, Y., Goto, Y., Idichi, T., Tanoue, K., Yamasaki, Y., Kawasaki, Y., Mataki, Y., et al. (2022) · Surgery · doi:10.1016/j.surg.2022.10.003 · Cited by 10

Mechanisms of crosstalk between the oropharyngeal microbiome and human papillomavirus in oropharyngeal carcinogenesis: a mini review

Chung, R. S., Wong, S., Lin, D., Kokot, N., Sinha, U. K., & Han, A. Y. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1425545 · Cited by 10

A prognostic model for stratification of stage IB/IIA esophageal squamous cell carcinoma: a retrospective study

Wu, L., Ma, Q., Huang, W., Liu, X., Qiu, L.-H., Lin, P., Long, H., Zhang, L., & Ma, G. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01636-5 · Cited by 10

Self-Assembled PHMB Titanium Coating Enables Anti-Fusobacterium nucleatum Strategy

Zhao, J., Jin, S., Delgado, A. H. S., Chen, Z., Matinlinna, J. P., & Tsoi, J. K. H. (2021) · Coatings · doi:10.3390/coatings11101190 · Cited by 10

Oral microbiome as a new research-target for supportive care and precision oncology

Bruno, J. S., & Fregnani, E. R. (2023) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000947 · Cited by 11

Oral Function and the Oral Microbiome in the Elderly in the Kyotango Area

Yamamoto, Y., Yamamoto, T., Miyamoto, N., Kinoshita, K., Nishikawa, S., Adachi, T., Takizawa, S., Inoüe, R., Matoba, S., & Kanamura, N. (2024) · Dentistry Journal · doi:10.3390/dj12010016 · Cited by 9

Changes in the gut microbiome of patients with esophageal cancer: A systematic review and meta-analysis based on 16S gene sequencing technology

Deng, J., Huang, Y., Yu, K., Luo, H., Zhou, D., & Li, D. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106784 · Cited by 9

The emerging role of Fusobacteria in carcinogenesis

Gibbs, R. J., Chambers, A., & Hill, D. J. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14353 · Cited by 9

Bladder cancer microbiome and its association with chemoresponse

Ginwala, R., Bukavina, L., Sindhani, M., Nachman, E. J., Peri, S., Franklin, J., Drevik, J. A., Christianson, S. S., Geynisman, D. M., Kutikov, A., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1506319 · Cited by 11

Interaction of intratumoral microbiota with the tumor immune microenvironment and its impact on cancer progression

Tingting, Y., Xiaoling, Z., Zhang, Y., Luo, Y., Luo, Y., Xueqin, S., & Shikai, T. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1609889 · Cited by 9

Bacteriophage FNU1 negates Fusobacterium nucleatum induced cell growth, migration and chemotherapy resistance in gastrointestinal cancer cells

Kabwe, M., Ayelign, B., Afshar‐Sterle, S., Büchert, M., & Tucci, J. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1721411 · Cited by 10

A Plausible Proposition of CCL20-Related Mechanism in Fusobacterium nucleatum-Associated Oral Carcinogenesis

Mandal, D. P., Mohanty, N., Behera, P. K., Gopinath, D., Panda, S., Kheraif, A. A. A., Divakar, D. D., Anil, S., & Panda, S. (2021) · Life · doi:10.3390/life11111218 · Cited by 9

The role of Fusobacteria in oral cancer and immune evasion

Harrandah, A. M. (2023) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000927 · Cited by 9

Relevance of tumor microbiome in cancer incidence, prognosis, and its clinical implications in therapeutics

Bahuguna, A., & Dubey, S. K. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188956 · Cited by 9

Fusobacterium nucleatum and the Immune System in Colorectal Cancer

Borroni, E. M., Qehajaj, D., Farina, F. M., Yiu, D., Bresalier, R. S., Chiriva‐Internati, M., Mirandola, L., Štifter, S., Laghi, L., & Grizzi, F. (2019) · Current Colorectal Cancer Reports · doi:10.1007/s11888-019-00442-2 · Cited by 9

Professional Oral Care Reduces Carcinogenic Acetaldehyde Levels in Mouth Air of Perioperative Esophageal Cancer Patients: A Prospective Comparative Study

Tanda, N., Washio, J., Kamei, T., Akazawa, K., Takahashi, N., & Koseki, T. (2019) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.249.75 · Cited by 9

CEACAM1 Activation by CbpF-Expressing E. coli

Shhadeh, A., Galaski, J., Alon‐Maimon, T., Fahoum, J., Wiener, R., Slade, D. J., Mandelboim, O., & Bachrach, G. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.699015 · Cited by 9

Microbiota Alterations in Gastrointestinal Cancers

Karwowska, Z., Szemraj, J., & Karwowski, B. T. (2020) · Applied Sciences · doi:10.3390/app10020585 · Cited by 9

Impact of the gut microbiome on response and toxicity to chemotherapy in advanced esophageal cancer

Li, N., Gao, L., Ge, Y., Zhao, L., Wang, Y., & Bai, C. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32770 · Cited by 11

Evaluation of the Oesophagogastric Cancer-Associated Microbiome: A Systematic Review and Quality Assessment

Vadhwana, B., Tarazi, M., Boshier, P. R., & Hanna, G. B. (2023) · Cancers · doi:10.3390/cancers15102668 · Cited by 8

Linking periodontitis with 20 cancers, emphasis on oropharyngeal cancer: a Mendelian randomization analysis

Xiong, J., Liu, H., Li, C., Li, Y., & Feng, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-63447-4 · Cited by 10

Tumor‐Resident Microbiota‐Based Risk Model Predicts Neoadjuvant Therapy Response of Locally Advanced Esophageal Squamous Cell Carcinoma Patients

Wu, H., Liu, Q., Li, J., Leng, X., He, Y., Liu, Y., Zhang, X., Ouyang, Y., Liu, Y., Liang, W., et al. (2024) · Advanced Science · doi:10.1002/advs.202309742 · Cited by 10

Crosstalk Between the Intratumoral Microbiota and the Tumor Microenvironment: New Frontiers in Solid Tumor Progression and Treatment

Zhou, Q., Zhou, L., Chen, X., Chen, Q., & Hao, L. (2024) · Cancer Reports · doi:10.1002/cnr2.70063 · Cited by 8

Distinct microbiome dysbiosis and epigenetic anomaly in esophageal adenocarcinoma and its underlying Barrett’s esophagus

Shijimaya, T., Tahara, T., Yamazaki, J., Kobayashi, S., Matsumoto, Y., Nakamura, N., Takahashi, Y., Tomiyama, T., Fukui, T., Shibata, T., et al. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01801-z · Cited by 8

The Association of Gut Microbiota and Complications in Gastrointestinal-Cancer Therapies

Tourelle, K. M., Boutin, S., Weigand, M. A., & Schmitt, F. C. F. (2021) · Biomedicines · doi:10.3390/biomedicines9101305 · Cited by 11

Fecal Microbes Associated with the Outcomes After Esophagectomy in Patients with Esophageal Cancer

Maruyama, S., Okamura, A., Kanie, Y., Sakamoto, K., Fujiwara, D., Kanamori, J., Imamura, Y., Takeda, K., & Watanabe, M. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-022-12166-z · Cited by 8

Preoperative evaluation of oral hygiene may predict the overall survival of patients with esophageal cancer

Watanabe, T., Sohda, M., Kim, M., Saito, H., Ubukata, Y., Nakazawa, N., Kuriyama, K., Hara, K., Sano, A., Sakai, M., et al. (2022) · Esophagus · doi:10.1007/s10388-022-00941-6 · Cited by 9

Whole-Transcriptome Sequencing Reveals Characteristics of Cancer Microbiome in Korean Patients with GI Tract Cancer: Fusobacterium nucleatum as a Therapeutic Target

Ahn, H., Min, K., Lee, E., Kim, H., Kim, S., Kim, Y.-J., Kim, G., Cho, B., Jeong, C., Kim, Y., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10101896 · Cited by 8

Alterations in the gut microbiome in patients with esophageal carcinoma in response to esophagectomy and neoadjuvant treatment

Hasuda, H., Ikeda, T., Makizaki, Y., Yokota, H., Tanaka, Y., Ohno, H., Shimokawa, M., Matsuoka, H., Kimura, Y., Oki, E., et al. (2022) · Surgery Today · doi:10.1007/s00595-022-02607-3 · Cited by 8

The Anti- and Pro-Tumorigenic Role of Microbiota and Its Role in Anticancer Therapeutic Strategies

Greco, G., Zeppa, S. D., Agostini, D., Attisani, G., Stefanelli, C., Ferrini, F., Sestili, P., & Fimognari, C. (2022) · Cancers · doi:10.3390/cancers15010190 · Cited by 8

Interaction of microbiota, mucosal malignancies, and immunotherapy—Mechanistic insights

Mager, L. F., Krause, T., & McCoy, K. D. (2024) · Mucosal Immunology · doi:10.1016/j.mucimm.2024.03.007 · Cited by 8

Emerging roles of intratumoral microbiota: a key to novel cancer therapies

Fang, P., Yang, H. J., Zhang, H., Shuai, D., Li, M., Chen, L., & Liu, L. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1506577 · Cited by 7

Association of Intratumoral Bacterial Abundance With Lung Cancer Prognosis in Chiba University Hospital Cohort

Ochi, T., Fujiki, R., Fukuyo, M., Rahmutulla, B., Nakagawa, T., Ota, M., Ikeda, J., Matsui, Y., Yoshino, I., Suzuki, H., et al. (2025) · Cancer Science · doi:10.1111/cas.70080 · Cited by 8

Fusobacterium nucleatum promotes metastasis of breast cancer via the miR-21-3p/FOXO3 axis

Huang, Y., Guo, Z., Zeng, Z., Shang, C., Zhang, Y., Ran, Z., Luo, G., Shen, S., Liu, Y., Zhou, P., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1530269 · Cited by 7

Co‐Infection by Porphyromonas gingivalis and Fusobacterium nucleatum Increases PD‐L1 Expression in Esophageal Cancer Tissues

Lin, X., Chen, X., Chen, M., Li, Y., Deng, Y., Xian, B., & Li, Z. (2025) · MicrobiologyOpen · doi:10.1002/mbo3.70050 · Cited by 7

Exploring the Microbiome in Breast Cancer: The Role of Fusobacterium nucleatum as an Onco-Immune Modulator

D’Angelo, A., Zenoniani, A., Masci, M., Aceto, G. M., Piattelli, A., & Curia, M. C. (2025) · Microorganisms · doi:10.3390/microorganisms13091995 · Cited by 8

Intratumoral microbiome: a crucial regulating factor in development and progression of colorectal cancer

Fan, Y., Gu, X., Yang, H., Chen, Y., Fang, C., Deng, H., & Dai, L. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00376-2 · Cited by 8

Abstract 4930: Genetic and epigenetic characteristics of esophageal cancer tissues with microbiome fusobacterium nucleatum

Baba, Y., Yamamura, K., Nakagawa, S., Mima, K., Ishimoto, T., Iwatsuki, M., Sakamoto, Y., Yoshida, N., & Baba, H. (2017) · Cancer Research · doi:10.1158/1538-7445.am2017-4930 · Cited by 1

Fusobacterium Nucleatum Predicts a Risk for Esophageal Squamous Cell CarcinomaPreprint

Shi, C., Li, Z., Zheng, J., Kong, W., Fan, T., Jian, D., Cheng, X., Zhao, H., Ma, J., Tang, H., et al. (2020) · doi:10.21203/rs.3.rs-101163/v1 · Cited by 1

Intratumoral Fusobacterium nucleatum Drives Cancer‐Associated Fibroblasts Enrichment and Immune Exclusion in Esophageal Squamous Cell Carcinoma

Ofuchi, T., Shinjo, K., Hu, Q., Omachi, K., Kanemitsu, K., Otsu, H., Yonemura, Y., Tobo, T., Baba, Y., Iwatsuki, M., et al. (2025) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.70116 · Cited by 4

Fusobacterium nucleatum predicts a high risk of metastasis for esophageal squamous cell carcinoma

Shi, C., Li, Z., Zheng, J., 孔为民, Fan, T., Jian, D., Cheng, X., Zhao, H., Ma, J., Tang, H., et al. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02352-6 · Cited by 74

Sa1836 - Fusobacterium Nucleatum Status Predicts Prognosis and Chemotherapeutic Response in Esophageal Cancer

Yamamura, K., Kandimalla, R., Izumi, D., Kodera, Y., Baba, H., & Goel, A. (2018) · Gastroenterology · doi:10.1016/s0016-5085(18)31659-7